Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Primary plasma cell leukemia 2.0: advances in biology and clinical management.

Expert review of hematology - 1 Nov 2016

Neri Antonino, Todoerti Katia, Lionetti Marta, Simeon Vittorio, Barbieri Marzia, Nozza Filomena, Vona Gabriella, Pompa Alessandra, Baldini Luca, Musto Pellegrino

Abstract excerpt

INTRODUCTION: Primary plasma cell leukemia (PPCL) is a rare and aggressive variant of multiple myeloma. The introduction of novel agents and modern technologies has recently partially changed the clinical and biological scenario of this malignancy, allowing limited, but not negligible, progresses. Areas covered: We will discuss: the complex landscape of genetic alterations in PPCL, derived from conventional and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to Genetic Testing

Share to Genomics

Share to Hematopoietic Stem Cell Transplantation

Share to Molecular Targeted Therapy

Share to Prognosis

Source

Identifiers

PMID: 27759436
DOI: 10.1080/17474086.2016.1244002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Primary plasma cell leukemia 2.0: advances in biology and clinical management.PMID 27759436Read ↗

Molecular Classification and Pharmacogenetics of Primary Plasma Cell Leukemia: An Initial Approach toward Precision MedicineSemantic proximity Read ↗

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.Semantic proximity Read ↗

Plasma cell leukemia: update on biology and therapy.Semantic proximity Read ↗

Multiple Myeloma and Precursor Plasma Cell Disorders: From Emerging Driver Mutations to Current and Future Therapeutic StrategiesSemantic proximity Read ↗

Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatmentSemantic proximity Read ↗

Transcriptional Characterization of a Prospective Series of Primary Plasma Cell Leukemia Revealed Signatures Associated with Tumor Progression and Poorer OutcomeSemantic proximity Read ↗

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read ↗

Genomics of Plasma Cell LeukemiaSemantic proximity Read ↗

Primary plasma cell leukemias displaying t(11;14) have specific genomic, transcriptional, and clinical featuresSemantic proximity Read ↗

Primary Plasma Cell Leukemia: Identity Card 2016.Semantic proximity Read ↗

Epidemiology, genetics and treatment of multiple myeloma and precursor diseases.Semantic proximity Read ↗

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.